SavedAdd your journal

Journals / İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi / 2026 / Cilt: 10 Sayı: 1

The Evaluation of COVID-19 Vaccine Hesitancy Level in Pregnant Women

Gebelerin COVID-19 Aşı Kararsızlığı Düzeyinin Değerlendirilmesi

Burçin Bektaş Pardes(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE HEMŞİRELİK FAKÜLTESİ, HEMŞİRELİK BİLİMLERİ BÖLÜMÜ, DOĞUM VE KADIN HASTALIKLARI HEMŞİRELİĞİ ANABİLİM DALI)0000-0003-0333-7461
Mehmet Ferdi Kıncı(İzmir Bayraklı City Hospital, Obstetrics and Gynecology Department)0000-0003-0487-1201
Berican Şahin Uyar(Muğla University Educational Research Hospital, Obstetrics and Gynecology Department)0000-0003-1463-7021
Firangiz Mirzazada(Denizli Special Cerrahi Hospital, Obstetrics and Gynecology Department)0000-0003-0677-3584
Begüm Köse(İzmir Bayraklı City Hospital, Obstetrics and Gynecology Department)0009-0006-1851-8133
Ahmet Akın Sivaslıoğlu(İzmir Ekonomi University Medical Point Hospital, Obstetrics and Gynecology Department)0000-0003-3711-0118
Pages
49–53
Publication Date
2025-01-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to the results of our study, the COVID-19 vaccine hesitancy rate is low compared to the current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The most common cause of COVID-19 vaccine hesitancy is fear of side effects and unknown long-term results.
📊
Key Findings & Data:This study aimed to determine the COVID-19 vaccine instability level of pregnant women followed up in a training and research hospital in Turkiye.
💡
Conclusion & Impact:Conclusion: According to the results of our study, the COVID-19 vaccine hesitancy rate is low compared to the current literature.
🔬Design:Survey & Empirical Study
📍Scope:2022 Verileri
⚙️Variables:COVID-19 · gebelik · aşı kararsızlığı

Abstract

Objective: The most common cause of COVID-19 vaccine hesitancy is fear of side effects and unknown long-term results. This study aimed to determine the COVID-19 vaccine instability level of pregnant women followed up in a training and research hospital in Turkiye. Material and Method: This prospective survey study was conducted in Mugla Sıtkı Kocman University (MSKU) Hospital pregnancy outpatient clinic between dates June- August 2022 through face-to-face interviews. Totally 380 pregnant women were included in the study. Research data were collected using the Sociodemographic Data Collection Form and the COVID-19 Vaccine Hesitancy Scale. Statistical significance level was accepted as p< 0.05. Results: The mean age of the pregnant women participating in the study was 26.05±10.22 and their mean gestational week was 24.20±12.30. The mean score of COVID-19 vaccine hesitancy scale was 15.85±6.44. The COVID-19 vaccine acceptance rate of pregnant women was found to be 76%. Conclusion: According to the results of our study, the COVID-19 vaccine hesitancy rate is low compared to the current literature. It is thought that the reason for the increase in the vaccine acceptance rate is the increase in the number of vaccinated pregnant women and the confidence that has arisen due to the lack of complications.

Özet

Amaç: COVID-19 aşı kararsızlığının en sık nedeni, yan etki endişesi ve uzun dönem sonuçlarının bilinmemesidir. Bu çalışmada, Türkiye’de bir eğitim araştırma hastanesinde takip edilen gebelerin COVID-19 aşı kararsızlığı düzeyinin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Bu tanımlayıcı prospektif çalışma, Muğla Sıtkı Koçman Üniversitesi (MSKÜ) Hastanesi gebe polikliniğinde yüz yüze görüşme yöntemiyle Haziran-Ağustos 2022 tarihleri arasında yapılmıştır. Çalışmaya toplam 380 gebe kadın dahil edilmiştir. Araştırma verileri Sosyodemografik Veri Toplama Formu ve COVID-19 Aşı Kararsızlığı Ölçeği kullanılarak toplanmıştır. İstatistiksel anlamlılık düzeyi p<0.05 olarak kabul edilmiştir. Bulgular: Çalışmaya katılan gebelerin yaş ortalaması 26,05±10,22 ve gebelik haftası ortalaması 24,20±12,30’dur. COVID-19 aşı kararsızlığı ölçeği toplam puan ortalaması 15,85±6,44 olarak bulunmuştur. Gebelerin COVID-19 aşısı kabul oranı ise %76 olarak saptanmıştır. Sonuç: Çalışmanın sonuçlarına göre COVID-19 aşı kararsızlık oranı güncel literatüre göre düşük bulunmuştur. Bu oranın düşmesinde aşılanan gebe sayısının artması ve aşının komplikasyon oluşturmaması etkili olmuştur.

🔖

Cite This Article

Pardes, B. B., Kıncı, M. F., Uyar, B. Ş., Mirzazada, F., Köse, B., Sivaslıoğlu, A. A. (2025). The Evaluation of COVID-19 Vaccine Hesitancy Level in Pregnant Women. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Cilt: 10 Sayı: 1, 49–53. https://doi.org/10.61399/ikcusbfd.1481463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Aslan MM, Uslu H, Köse O, Cevrioğlu S, Özden S. COVID-19 ve gebelik. J Biotechnol and Strategic Health Res. 2020;4:10-13. DOI: 10.34084/ bshr.713716.
  2. Özcan H, Elkoca A, Yalçın Ö. COVID-19 enfeksiyonu ve gebelik üzerindeki etkileri. Anatol Clin. 2020;25(Special Issue on COVID 19):43- 50. DOI: 10.21673/anadoluklin.708151.
  3. Şehirli Kıncı Ö, Kıncı MF, Mirzazade F, Yılmaz HO, Saruhan E, Sivaslıoğlu, AA. Maternal and neonatal outcomes of pregnant women with SARS-CoV-2 infection in our tertiary hospital. Perinatal Journal. 2022;30(3):301–307. DOI: 10.2399/prn.22.0303012.
  4. Yavuz E. COVID-19 aşıları. Türk Aile Hek Derg. 2020;24(4):227-234. DOI:10.15511/tahd.20.00427.
  5. Rasmussen, SA, Kelley, CF, Horton, JP, Jamieson, DJ. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know. Obstet Gynecol. 2021;137(3):408-414. DOI: 10.1097/ AOG.0000000000004290.
  6. Desdicioğlu R, Avşar FB, Yavuz, AF. COVID-19 aşıları ve gebelik. Ankara Med J. 2021;4:672-686. DOI: 10.5505/amj.2021.22120.
  7. World Health Organization (WHO). Report of the SAGE working group on vaccine hesitancy. 2014. [cited 2023 Nov 11]. Available from https:// www.asset-scienceinsociety.eu/sites/default/files/sage_working_ group_revised_report_vaccine_hesitancy.pdf.
  8. Shen SC, Dubey V. Addressing vaccine hesitancy: clinical guidance for primary care physicians working with parents. Can Fam Physician. 2019;65(3):175-181.
  9. Erkekoğlu P, Erdemli Köse SB, Balcı A, Yirün A. Aşı kararsızlığı ve COVID-19’un etkileri. J Lit Pharm Sci. 2020;9(2):208-220. DOI: 10.5336/ pharmsci.2020-76102.
  10. Flight L, Julious SA. A practical guide to sample size calculations: Installation of the app SampSize. Pharmaceutical Statistics. 2022;21(5):1109-1110. DOI: 10.1002/pst.2215.
  11. Yeşilçiçek Çalık K, Erkaya R, Küçük E, Kanbay Y. COVID-19 aşı kararsızlığı ölçeği: Türkçe geçerlilik ve güvenirlik çalışması. GÜSBD. 2022;11(1):287-299. DOI: 10.37989/gumussagbil.943007.
  12. Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes and narratives survey (Oceans) II. Psychological Medicine. 2020;1-15. DOI: 10.1017/S0033291720005188
  13. Türk Perinatoloji Derneği. Gebelik doğum ve lohusalık döneminde “Yeni koronavirüs enfeksiyonu 2019” (COVID-19) hakkında Türk perinatoloji derneği görüşü. 2020. [cited 2023 Nov 15]. Available from https://www.perinatoloji.org.tr/gebelik-dogum-ve-lohusalik-doneminde-yeni-koronavirus-enfeksiyonu-2019-covid-19-hakkinda-turk-perinatoloji-dernegi-gorusu.
  14. Adhikari EH, Spong CY. COVID-19 vaccination in pregnant and lactating women. JAMA. 2021;325(11):1039-1040. DOI: 10.1001/ jama.2021.1658.
  15. Duong TV, Lin CY, Chen SC, Huang YK, Okan O, Dadaczynski K, et al. Oxford COVID-19 vaccine hesitancy in school principals: impacts of gender, well-being, and coronavirus-related health literacy. Vaccines. 2021;9(9):985. DOI: 10.3390/vaccines9090985.
  16. Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36(2):197-211. DOI: 10.1007/s10654- 021-00728-6.
  17. Yesilcinar İ, Güvenc G, Kıncı MF, Bektas Pardes B, Kök G, Sivaslioglu AA. Knowledge, fear and anxiety levels among pregnant women during the COVID-19 pandemic: a cross-sectional study. Clin Nurs Res. 2022;31(4):758-765. DOI: 10.1177/10547738221085662.,
  18. Dikmen HA. An investigation COVID-19 related knowledge, attitude, depression, anxiety and stress levels of pregnant women. ADYÜSağlık Bilimleri Derg. 2021;7(1):80-93. DOI: 10.30569/adiyamansaglik.816066.
  19. Ghamri RA, Othman SS, Alhiniah MH, Alelyani RH, Badawi AM, Alshahrani AA. Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia. Patient Prefer Adherence. 2022;16:861-873. DOI: 10.2147/PPA.S357653.
  20. Ceulemans M, Foulon V, Panchaud A, Winterfeld U, Pomar L, Lambelet V, et al. Vaccine willingness and impact of the COVID-19 pandemic on women’s perinatal experiences and practices—a multinational, cross- Sectional study covering the first wave of the pandemic. Int J Environ Res Public Health. 2021;18(7):3367. DOI: 10.3390/ijerph18073367.
  21. Kiefer MK, Mehl R, Costantine MM, Johnson A, Cohen J, Summerfield TL, et al. Characteristics and perceptions associated with COVID‐19 vaccination hesitancy among pregnant and postpartum individuals: a cross‐sectional study. BJOG. 2022;129:1342–1351. DOI: 10.1111/1471- 0528.17110.
  22. Kuciel N, Mazurek J, Hap K, Marciniak D, Biernat K, Sutkowska E. COVID-19 vaccine acceptance in pregnant and lactating women and mothers of young children in Poland. Int J Womens Health. 2022;14:415- 424. DOI: 10.2147/IJWH.S348652.
  23. Citu IM, Citu C, Gorun F, Motoc A, Gorun OM, Burlea B, et al. Determinants of COVID-19 vaccination hesitancy among Romanian pregnant women. Vaccines. 2022;10(2):275. DOI: 10.3390/ vaccines10020275.
  24. Carbone L, Di Girolamo R, Mappa I, Saccone G, Raffone A, Di Mascio D, et al. Worldwide beliefs among pregnant women on SARS-CoV-2 vaccine: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2022;268:144-164. DOI: 10.1016/j.ejogrb.2021.12.003.